Critical Survey Atara Biotherapeutics versus Vericel
ATRA Stock | USD 7.96 0.01 0.13% |
About 63% of Atara Biotherapeutics' investor base is looking to short. The analysis of overall sentiment of trading Atara Biotherapeutics stock suggests that many investors are alarmed at this time. The current market sentiment, together with Atara Biotherapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Atara Biotherapeutics stock news signals to limit their universe of possible portfolio assets.
Atara Biotherapeutics and Vericel are both medical companies, but which is the superior business We will compare the two businesses based on the strength of their dividends, earnings, institutional ownership, risk, valuation, profitability and analyst recommendations. Insider and Institutional Ownership 70.9 percent of Atara Biotherapeutics shares
Read at thelincolnianonline.com
![]() |
Atara Biotherapeutics Fundamental Analysis
We analyze Atara Biotherapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Atara Biotherapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Atara Biotherapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Market Capitalization
Market Capitalization Comparative Analysis
Atara Biotherapeutics is currently under evaluation in market capitalization category among its peers. Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Atara Biotherapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Atara Biotherapeutics stock to make a market-neutral strategy. Peer analysis of Atara Biotherapeutics could also be used in its relative valuation, which is a method of valuing Atara Biotherapeutics by comparing valuation metrics with similar companies.
Peers
Atara Biotherapeutics Related Equities
ITOS | Iteos Therapeutics | 0.70 |
| ||
HOOK | Hookipa Pharma | 0.79 |
| ||
HRTX | Heron Therapeuti | 0.93 |
| ||
ALLO | Allogene Therapeutics | 1.67 |
| ||
SANA | Sana Biotechnology | 2.09 |
| ||
KPTI | Karyopharm Therapeutics | 2.23 |
| ||
MREO | Mereo BioPharma | 5.00 |
| ||
APLS | Apellis Pharmaceuticals | 5.27 |
| ||
TCRX | Tscan Therapeutics | 5.41 |
| ||
FATE | Fate Therapeutics | 5.45 |
| ||
RCUS | Arcus Biosciences | 6.47 |
| ||
CRBU | Caribou Biosciences | 6.67 |
| ||
ABOS | Acumen Pharmaceuticals | 7.44 |
| ||
XFOR | X4 Pharmaceuticals | 8.50 |
| ||
BTAI | BioXcel Therapeutics | 12.81 |
|
Complementary Tools for Atara Stock analysis
When running Atara Biotherapeutics' price analysis, check to measure Atara Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atara Biotherapeutics is operating at the current time. Most of Atara Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Atara Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atara Biotherapeutics' price. Additionally, you may evaluate how the addition of Atara Biotherapeutics to your portfolios can decrease your overall portfolio volatility.
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |